Skip to main content

ASCO: Bone Meds, Esophageal Cancers Linked

The esophageal cancer risk with bisphosphonate bone drugs may be a bigger problem than thought, particularly with use of alendronate (Fosamax), an adverse event surveillance study suggested.
http://www.medpagetoday.com/HematologyOncology/OtherCancers/32992?utm_content=&utm_medium=email&utm_campaign=DailyHeadlines&utm_source=WC&eun=g424100d0r&userid=424100&email=joannenicholas@gmail.com&mu_id=5523180

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2024 Esophageal Cancer Education Foundation- by domino